rSIFN-co Among Healthy Subjects and Subjects With Mild or Asymptomatic COVID-19
Clinical trial NCT05485584 · COMPLETED
Trial details
- NCT number
- NCT05485584
- Sponsor
- Sichuan Huiyang Life Science and Technology Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-01
- Primary completion
- 2023-04-05
- Enrollment
- 188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.